Terms: = Pancreatic cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
6 results:
1. Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in pancreatic cancer.
Jiang W; Du Y; Zhang W; Zhou W
Can J Gastroenterol Hepatol; 2022; 2022():4661929. PubMed ID: 36406148
[TBL] [Abstract] [Full Text] [Related]
2. Bifacial PNAs Destabilize malat1 by 3' A-Tail Displacement from the U-Rich Internal Loop.
Miao S; Bhunia D; Devari S; Liang Y; Munyaradzi O; Rundell S; Bong D
ACS Chem Biol; 2021 Aug; 16(8):1600-1609. PubMed ID: 34382766
[TBL] [Abstract] [Full Text] [Related]
3. Long noncoding RNAs: role and contribution in pancreatic cancer.
Ramya Devi KT; Karthik D; Mahendran T; Jaganathan MK; Hemdev SP
Transcription; 2021 Feb; 12(1):12-27. PubMed ID: 34036896
[TBL] [Abstract] [Full Text] [Related]
4. Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer.
Cheng Y; Imanirad P; Jutooru I; Hedrick E; Jin UH; Rodrigues Hoffman A; Leal de Araujo J; Morpurgo B; Golovko A; Safe S
PLoS One; 2018; 13(2):e0192264. PubMed ID: 29389953
[TBL] [Abstract] [Full Text] [Related]
5. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
Taucher V; Mangge H; Haybaeck J
Cell Oncol (Dordr); 2016 Aug; 39(4):295-318. PubMed ID: 27060060
[TBL] [Abstract] [Full Text] [Related]
6. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW
Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980
[TBL] [Abstract] [Full Text] [Related]
